Largely because of the unprecedented marketing by the pharmaceutical industry as well as the transition of behavioral health to primary care venues, spending for psychiatric drugs has increased to over $40 billion in sales in 2010. Concurrently, the use of psychotherapy has declined and community behavioral health intervention has fallen or remained flat. Are these patterns justified by the clinical trial evidence?
This conference answers that question but more importantly offers effective, empirically demonstrated non-medical solutions for behavioral and emotional problems typically treated only with psychotropics. In the spirit of evidence- based medicine’s inclusion of patient values as well as the movement toward health homes, this conference brings together the foremost experts in the field to present viable alternatives to medication, as well as guidelines to raise the bar of care equal to the available science.